Ribosomal and non-ribosomal resistance to oxazolidinones: Species-specific idiosyncrasy of ribosomal alterations

Molecular Microbiology

Volumn 46, Issue 5, 2002, Pages 1295-1304

  Sander, P ^a   Belova, L ^b   Kidan, Y G ^c   Pfister, P ^a   Mankin, A S ^b   Bottger E C ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LINEZOLID; OXAZOLIDINONE DERIVATIVE; PEPTIDYLTRANSFERASE; PNU 176798; RNA; UNCLASSIFIED DRUG; ACETAMIDE DERIVATIVE; ANTIINFECTIVE AGENT; BACTERIAL RNA; RNA 23S;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; CLONE; CROSS RESISTANCE; GENE MUTATION; GENE SEQUENCE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; IN VITRO STUDY; MYCOBACTERIUM SMEGMATIS; NONHUMAN; OPERON; PRIORITY JOURNAL; RIBOSOME; WILD TYPE; CHEMISTRY; DRUG EFFECT; ESCHERICHIA COLI; GENETICS; MICROBIOLOGICAL EXAMINATION; MOLECULAR GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; SPECIES DIFFERENCE;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; MYCOBACTERIUM; MYCOBACTERIUM SMEGMATIS; NEGIBACTERIA; POSIBACTERIA;

ACETAMIDES; ANTI-BACTERIAL AGENTS; BASE SEQUENCE; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MICROBIAL; ESCHERICHIA COLI; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MUTATION; MYCOBACTERIUM SMEGMATIS; OXAZOLIDINONES; RIBOSOMES; RNA, BACTERIAL; RNA, RIBOSOMAL, 23S; RRNA OPERON; SPECIES SPECIFICITY;

EID: 0036886952     PISSN: 0950382X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2958.2002.03242.x     Document Type: Article

References (36)

1. Aoki, H., Ke, L., Poppe, S.M., Poel, T.J., Weaver, E.A., Gadwood, R.C., et al. (2002) Oxazolidinone antibiotics target the P site on Escherichia coli ribosomes. Antimicrob Agents Chemother 46: 1080-1085.
2. Böttger, E.C., Springer, B., Prammananan, T., Kidan, Y., and Sander, P. (2001) Structural basis for selectivity and toxicity of ribosomal antibiotics. EMBO Rep 2: 318-323.
3. Brickner, S.J., Hutchinson, D.K., Barachyn, M.R., Manninen, P.R., Ulanowicz, D.A., Garmon, S.A., et al. (1996) Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant gram-positive bacterial infections. J Med Chem 39: 673-679.
4. Corti, G., Cinelli, R., and Paradisi, F. (2000) Clinical and microbiologic efficacy and safety profile of linezolid, a new oxazolidinone antibiotic. Int J Antimicrob Agents 16: 527-530.
5. Cundliffe, E. (1990) Recognition sites for antibiotics within rRNA. In The Ribosome: Structure, Function and Evolution. Hill, W.E., Dahlberg, A., Garrett, R.A., Moore, P.B., Schlessinger, D., and Warner, J.R. (eds). Washington, DC: American Society for Microbiology Press, pp. 479-490.
6. Eustice, D.C., Feldman, P.A., Zahac, I., and Slee, A.M. (1988) Mechanism of action of DuP 721: inhibition of an early event during initiation of protein synthesis. Antimicrob Agents Chemother 32: 1218-1222.
7. Gonzales, R.D., Schreckensberger, P.C., Graham, M.B., Kelkar, S., DenBesten, K., and Quinn, J.P. (2001) Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid. Lancet 357: 1179.
8. Ji, Y., Colston, M.J., and Cox, R.A. (1994) The ribosomal RNA (rrn) operons of fast-growing mycobacteria: primary and secondary structures and their relation to rrn operons of pathogenic slow-growers. Microbiology 140: 2829-2840.
9. Jones, R.N., Della-Latta, P., Lee, L.V., and Biedenbach, D.J. (2002) Linezolid-resistant Enterococcus faecium isolated from a patient without prior exposure to an oxazolidinone: report from the SENTRY antimicrobial surveillance program. Diagn Micobiol Infect Dis 42: 137-139.
10. Kloss, P., Xiong, L., Shinabarger, D., and Mankin, A.S. (1999) Resistance mutations in 23S rRNA identify the site of action of protein synthesis inhibitor, linezolid, in the ribosomal peptidyl transferase center. J Mol Biol 294: 93-101.
11. Lin, A.H., Murray, R.W., Vidmar, T.J., and Marotti, K.R. (1997) The oxazolidinone eperezolid binds to the 50S ribosomal subunit and competes with binding of chloramphenicol and lincomycin. Antimicrob Agents Chemother 41: 2127-2131.
12. Marcker, K.A. (1965) The formation of N-formyl-methionyl-tRNA. J Mol Biol 14: 63-70.
13. Matassova, N.B., Rodnina, M.V., Endermann, R., Kroll, H.-P., Pleiss, U., Wild, H., and Wintermeyer, W. (1999) Ribosomal RNA is the target for oxazolidinones, a novel class of translational inhibitors. RNA 5: 939-946.
14. Monro, R.E., and Marcker, K.A. (1967) Ribosome-catalysed reaction of puromycin with a formyl-methionine-containing oligonucleotide. J Mol Biol 25: 347-350.
15. Murray, R.W., Schaadt, R.D., Zurenko, G.E., and Marotti, K.R. (1998) Ribosomes from an oxazolidinone-resistant mutant confer resistance to eperezolid in a Staphylococcus aureus cell-free transcription-translation assay. Antimicrob Agents Chemother 42: 947-950.
16. Nagaev, I., Bjorkman, J., Andersson, D.I., and Hughes, D. (2001) Biological cost and compensatory evolution in fusidJc acid-resistant Staphylococcus aureus. Mol Microbiol 40: 433-439.
17. Nissen, P., Hansen, J., Ban, N., Moore, P.B., and Steitz, T.A. (2000) The structural basis of ribosome activity in peptide bond synthesis. Science 289: 920-930.
18. Norrby, R. (2001) Linezolid - a review of the first oxazolidinone. Exp Opin Pharmacother 2: 293-302.
19. Polacek, N., Gaynor, M., Yassin, A., and Mankin, A.S. (2001) Ribosomal peptidyl transferase can withstand mutations at the putative catalytic nucleotide. Nature 411: 498-501.
20. wt strains. Antimicrob Agents Chemother 43: 447-453.
21. Prystrowsky, J., Siddiqui, F., Chosay, J., Shinabarger, D.L., Millichap, J., Peterson, L.R., and Noskin, G.A. (2001) Resistance to linezolid: characterization of mutations in rRNA and comparison of their occurrences in vancomycin-resistant enterococci. Antimicrob Agents Chemother 45: 2154-2156.
22. Sander, P., Prammananan, T., and Böttger, E.C. (1996) Introducing mutations into a chromosomal rRNA gene using a genetically modified eubacterial host with a single rRNA operon. Mol Microbiol 22: 841-848.
23. Sander, P., Prammananan, T., Meier, A., Frischkorn. K., and Böttger, E.C. (1997) The role of ribosomal RNAs in macrolide resistance. Mol Microbiol 26: 469-480.
24. Sander, P., Springer, B., Prammananan, T., Sturmfels, A., Kappler, M., Pletschette, M., and Böttger, E.C. (2002) Fitness cost of chromosomal drug resistance conferring mutations. Antimicrob Agents Chemother 46: 1204-1211.
25. Schluenzen, F., Zaivach, R., Harms, J., Bashan, A., Tocilj, A., Albrecht, R., et al. (2001) Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria. Nature 413: 814-821.
26. Shinabarger, D.L. (1999) Mechanisms of action of the oxazolidinone antibacterial agents. Exp Opin Invest Drugs 8: 1195-1202.
27. Shinabarger, D.L., Marotti, K.R., Murray, R.W., Lin, A.H., Melchior, E.P., Swaney, S.M., et al. (1997) Mechanism of action of oxazolidinones: effects of linezolid and eperezolid on translation reactions. Antimicrob Agents Chemother 41: 2132-2136.
28. Snapper, S.B., Melton, R.E., Mustafa, S., Kieser, T., and Jacobs, W.R. (1990) Isolation and characterization of efficient plasmid transformation mutants of Mycobacterium smegmatis. Mol Microbiol 4: 1911-1919.
29. Spedding, G. (1990) Isolation and analysis of ribosomes from prokaryotes eukaryotes, and organelles. In Ribosomes and Protein Synthesis, a Practical Approach. Spedding, G. (ed.). Oxford: Oxford University Press, pp. 1-29.
30. Swaney, S.M., Aoki, H., Ganoza, M.C., and Shinabarger, D.L. (1998) The oxazolidinone linezolid inhibits initiation of protein synthesis in bacteria. Antimicrob Agents Chemother 42: 3251-3255.
31. Thompson, J., Kim, D.F., O'Connor, M., Lieberman, K.R., Bayfield, M.A., Gregory, S.T., et al. (2001) Analysis of mutations at residue A2451 and G2447 of 23S rRNA in the peptidyltransferase active site of the 50S ribosomal subunit. Proc Natl Acad Sci USA 98: 9002-9007.
32. Tsiodras, S., Gold, H.S., Sakoulas, G., Eliopoulos, G.M., Winnersten, C., Venkataraman, L., and Moellering, R.C. (2001) Linezolid resistance in a clinical isolate of Staphylococcus aureus. Lancet 358: 207-208.
33. Xiong, L., Kloss, P., Douthwaite, S., Andersen, N.M., Swaney, S., Shinabarger, D.L., and Mankin, A.S. (2000) Oxazolidinone resistance mutations in 23S rRNA of Escherichia coli reveal the central region of domain V as the primary site of drug action. J Bacteriol 182: 5325-5331.
34. Xiong, L., Polacek, N., Sander, P., Böttger. E.C., and Mankin, A. (2001) pKa of adenine 2451 in the ribosomal peptidyl transferase center remains elusive. RNA 7: 1365-1369.
35. Zurenko, G.E., Yagi, B.H., Schaadt, R.D., Allison, J.W., Kilburn, J.O., Glickman, S.E. et al. (1996) In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents. Antimicrob Agents Chemother 40: 839-845.
36. Zurenko, G.E., Gibson, J.K., Shinabarger, D.L., Aristoff, P.A., Ford, C.W., and Tarpley, W.G. (2001) Oxazolidinones: a new class of antibacterials. Curr Opin Pharmacol 1: 470-476.